"Anti-Anxiety Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
| Descriptor ID |
D014151
|
| MeSH Number(s) |
D27.505.696.277.950.015 D27.505.954.427.210.950.015 D27.505.954.427.700.872.015
|
| Concept/Terms |
Anti-Anxiety Agents- Anti-Anxiety Agents
- Agents, Anti-Anxiety
- Anti Anxiety Agents
- Anxiolytic Agents
- Agents, Anxiolytic
- Tranquilizing Agents, Minor
- Agents, Minor Tranquilizing
- Minor Tranquilizing Agents
- Tranquillizing Agents, Minor
- Agents, Minor Tranquillizing
- Minor Tranquillizing Agents
- Anti-Anxiety Drugs
- Anti Anxiety Drugs
- Drugs, Anti-Anxiety
- Anxiolytics
Anti-Anxiety Effect- Anti-Anxiety Effect
- Anti Anxiety Effect
- Effect, Anti-Anxiety
- Anxiolytic Effects
- Effects, Anxiolytic
- Antianxiety Effects
- Effects, Antianxiety
- Anxiolytic Effect
- Effect, Anxiolytic
- Anti-Anxiety Effects
- Anti Anxiety Effects
- Effects, Anti-Anxiety
- Antianxiety Effect
- Effect, Antianxiety
|
Below are MeSH descriptors whose meaning is more general than "Anti-Anxiety Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Anxiety Agents".
This graph shows the total number of publications written about "Anti-Anxiety Agents" by people in this website by year, and whether "Anti-Anxiety Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 2 | 5 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 2 | 4 |
| 2009 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Anxiety Agents" by people in Profiles.
-
Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):83-91.
-
Psychogenic Non-epileptic Seizures: An Updated Primer. Psychosomatics. 2016 Jan-Feb; 57(1):1-17.
-
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. Neuropsychopharmacology. 2015 Jul; 40(8):2025-37.
-
Response to Silberman. Am J Psychiatry. 2014 Jul; 171(7):795-6.
-
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53.
-
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31.
-
Refractory generalized anxiety disorder. J Clin Psychiatry. 2009; 70 Suppl 2:32-8.
-
Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
-
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
-
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.